Biomagnetic Technologies, Inc.
This article was originally published in The Gray Sheet
Executive Summary
Files registration statement for public offering of 3 mil. units. The San Diego-based manufacturer Of imaging systems estimates that it will sell the units for $5 to $7. Each unit is comprised of one share of common stock, one Class A Warrant and one Class B Warrant. Class A and Class B Warrants will give investors the option to obtain common stock at 125% and 150% of the unit price, respectively, for seven years. The offering is being managed by D. Blech & Company and will be preceded by a one-for-three reverse split of the common stock
You may also be interested in...
Pipeline Watch: Five Approvals And 23 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.